GTBP vs AMGN: Which Stock is Better?
Side-by-side comparison of Gt Biopharma Inc and Amgen Inc in 2026
GTBP
Gt Biopharma Inc
$0.73
AMGN
Amgen Inc
$331.00
Key Metrics Comparison
| Metric | GTBP | AMGN | Winner |
|---|---|---|---|
| Market Cap | $7.93M | $178.24B | AMGN |
| P/E Ratio | N/A | 25.58 | AMGN |
| EPS (TTM) | $N/A | $12.94 | AMGN |
| Revenue Growth | 0.0% | 0.1% | AMGN |
| Gross Margin | 0.0% | 70.1% | AMGN |
Analyze GTBP
Full quant analysis
Analyze AMGN
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is GTBP or AMGN a better investment?
Comparing GTBP and AMGN: Gt Biopharma Inc has a market cap of $7.93M while Amgen Inc has $178.24B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between GTBP and AMGN?
GTBP (Gt Biopharma Inc) and AMGN (Amgen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: GTBP or AMGN?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: GTBP or AMGN?
AMGN has higher revenue growth at 0.1% vs 0.0% for GTBP.
Which company is more profitable: GTBP or AMGN?
Amgen Inc (AMGN) has higher gross margins at 70.1% compared to 0.0% for GTBP.
Which is the larger company: GTBP or AMGN?
Amgen Inc (AMGN) is larger with a market cap of $178.24B compared to $7.93M for GTBP.
Should I buy GTBP or AMGN in 2026?
Both GTBP and AMGN have investment merit. GTBP trades at $0.73 while AMGN trades at $331.00. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between GTBP and AMGN stock?
Key differences: Market Cap ($7.93M vs $178.24B), P/E Ratio (N/A vs 25.6x), Revenue Growth (0.0% vs 0.1%), Gross Margin (0.0% vs 70.1%).